Retrospective Cohort Analysis Of Real-World Clinical Outcomes In Nonmetastatic (M0) Castration-Resistant Prostate Cancer (Crpc) Treated With Novel Androgen Receptor Pathway Inhibitors (Arpi).
JOURNAL OF CLINICAL ONCOLOGY（2021）
Abstract
51Background: The landscape of M0 CRPC has changed with the recent demonstration of metastasis-free survival (MFS) and overall survival (OS) improvements with the use of ARPIs in clinical trial set...
MoreTranslated text
Key words
prostate cancer,retrospective cohort analysis,real-world,castration-resistant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined